Intellia Therapeutics
NTLA
NTLA
302 hedge funds and large institutions have $2.69B invested in Intellia Therapeutics in 2022 Q4 according to their latest regulatory filings, with 49 funds opening new positions, 119 increasing their positions, 80 reducing their positions, and 60 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
302
Holders Change
-16
Holders Change %
-5.03%
% of All Funds
4.87%
Holding in Top 10
7
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-12.5%
% of All Funds
0.11%
New
49
Increased
119
Reduced
80
Closed
60
Calls
$22.8M
Puts
$11.7M
Net Calls
+$11.1M
Net Calls Change
+$803K
Top Buyers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
$69.6M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
$272M |
| 3 |
BlackRock
New York
|
$253M |
| 4 |
State Street
Boston,
Massachusetts
|
$131M |
| 5 |
Morgan Stanley
New York
|
$87.9M |
